Mouse anti Human HLA B27 antibody, clone HLA-ABC-m3 recognizes the HLA-B27 alloantigen. This antibody reacts with the peripheral blood lymphocytes of 47/47 individuals conventionally typed as HLA-B27 + and precipitates cell surface molecules of 43 and 12 kD, corresponding to the HLA Class 1 heavy chain and beta 2 microglobulin.
Affinity studies by Scatchard analysis showed that this antibody has a higher affinity for HLA-B27 (9.7 x 108M-1) than for HLA B7 (9.5 x 107 M-1).
Subjects Expected Fluorescence Intensity Heterozygous HLA-B27+ Strong Homozygous HLA-B27+ Strong Heterozygous HLA-B7+ Faint Non B27, Non B7 Negative
- Target Species
- Product Form
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC) - liquid
- Purified IgG prepared by ion exchange chromatography
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.1% Sodium Azide (NaN3)
0.2% Bovine Serum Albumin
- Immune complex precipitated from an HLA-B27 positive cell line by anti HLA antibody and staphylococcal protein A.
- Approx. Protein Concentrations
- 50 ug/ml
- Store at +4oC.
DO NOT FREEZE.
This product should be stored undiluted. This product is photosensitive and should be protected from light. Should this product contain a precipitate we recommend microcentrifugation before use.
- 18 months from date of despatch.
- Entrez Gene
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of HLA B27 antibody
Where this antibody has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the antibody for use in their own system using appropriate negative/positive controls.
- Flow Cytometry
- Use 10ul of the suggested working dilution to label 106 cells or 100ul of whole blood.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Negative Isotype Controls Available
Useful Reagents Available
Product Specific References
References for HLA B27 antibody
Trapani, J.A. et al. (1983) Description of a mouse monoclonal anti-HLA-B27 antibody HLA-ABC-m3.
Hum Immunol. 7 (4): 205-16.
Orr, K. et al. (1994) Utilization of commercial antisera and flow cytometry in HLA-B27 typing.
Cytometry (Comm. Clin. Cytometry) 18: 17-20.
Levering, W.H. et al. (2003) Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens.
Cytometry B Clin Cytom. 54: 28-38.
Mandic, R. et al. (2004) Comparison of surface HLA class I levels in squamous cell carcinoma cell lines of the head and neck.
Anticancer Res. 24 (2B): 973-9.
Goodall, J.C. et al. (2007) Does HLA-B27 influence the monocyte inflammatory response to lipopolysaccharide?
Rheumatology (Oxford). 46: 232-7.
Meyer, O. et al. (2006) A simple and practical agglutination assay for human leucocyte antigen-B27 typing.
Vox Sang. 91 (1): 77-80.
Meyer, O. et al. (2008) Application of the particle gel agglutination assay in the typing of single human leucocyte antigens.
Tissue Antigens. 71 (2): 157-9.
Marroquin, B. O et al. (2015) HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats.
PLoS One. 10 (6): e0130811.